Main > PHARMA. > Drug BioAvailability > Oral Drug BioAvailability > Improvement. > Essential Oils (USA.A) > Patent > Literature (Claims Etc.) > Claim 1: Oral BioAvailability of > Hydrophobic Drug Increase Method: > Co-Adm. Drug & Essential Oil or > Essential Oil Component to provide > Concn. of Essential Oil or Comp. in > Gut > than Concn. that Reduces > Cyclosporin (C) to Hydroxylated (C > ) Conversion by 10% in Assay Contg. > Rat Liver Microsomes (250 .mu.g)

---

Rat Liver Microsomes (250 .mu.g)'s subsections
Cyclosporin (1 .mu.M),

Rat Liver Microsomes (250 .mu.g)'s products
This section has no products